您好,欢迎访问江苏省农业科学院 机构知识库!

Enhanced Immunogenicity of Chicken H9N2 Influenza Inactivated Vaccine Through a Novel Dual-Targeting Fusion Protein Strategy

文献类型: 外文期刊

作者: Xu, Hai 1 ; Deng, Bihua 2 ; Wu, Erzhong 4 ; Zhu, Yalu 2 ; Qi, Qiurong 2 ; Feng, Yaming 1 ; Lu, Yu 3 ;

作者机构: 1.Jiangsu Acad Agr Sci, Inst Taizhou Agr Sci, Taizhou 225300, Peoples R China

2.GuoTai Taizhou Ctr Technol Innovat Vet Biol, Taizhou 225300, Peoples R China

3.Jiangsu Acad Agr Sci, Inst Vet Immunol & Engn, Nanjing 210014, Peoples R China

4.Taizhou Municipal Bur Agr & Rural Affairs, Anim Husb & Vet Dept, Taizhou 225300, Peoples R China

关键词: dual targeting; avian influenza; dendritic cell; envelope virus

期刊名称:VACCINES ( 影响因子:3.4; 五年影响因子:3.7 )

ISSN:

年卷期: 2025 年 13 卷 3 期

页码:

收录情况: SCI

摘要: Background/Objectives: Targeted delivery of antigens to dendritic cells (DCs) is an effective strategy for enhancing vaccine efficacy. Methods: In this study, dual-targeting fusion proteins (GRFT-VHH54 and GRFT-VHH74) were constructed by fusing Griffithsin (GRFT), an algae-derived lectin with enveloped virus-binding properties, to DC-specific binding nanobodies (VHH54 and VHH74). Vaccines were formulated by combining the inactivated H9N2 avian influenza virus with these fusion proteins, and the potential of the fusion proteins to enhance vaccine-induced immunity in chickens was systematically evaluated. For parallel comparison, control groups included H9N2 avian influenza vaccines containing the inactivated virus alone, the inactivated virus with the immune enhancer CVCVA5, and a commercial H9N2 avian influenza inactivated vaccine. Results: At 4 weeks post-immunization, chickens vaccinated with the inactivated H9N2 virus combined with the GRFT-VHH74 fusion protein (1/2 H9+GRFT-VHH74) exhibited significantly enhanced humoral, mucosal, and cellular immune responses compared to those vaccinated with the inactivated H9N2 virus alone or the commercial H9N2 vaccine (p < 0.05). Additionally, chickens in the 1/2 H9+GRFT-VHH74 group exhibited enhanced resistance to the heterologous H9N2 subtype avian influenza virus, achieving a 90% protection rate, which was higher than that of the other groups. Conclusions: These results indicate that the GRFT-VHH74 fusion protein has significant potential for advancing the development of inactivated vaccines against the H9N2 subtype avian influenza. Furthermore, it provides valuable insights for enhancing the immunogenicity and efficacy of inactivated vaccines targeting other avian influenza subtypes.

  • 相关文献
作者其他论文 更多>>